Bioethicists are outraged by 23andMe's patent on predicting traits in children. Should you be too?
Susan YoungFollow @twitterapi
I’m the biomedicine editor for MIT Technology Review. I look for stories where technology stands to improve human health or advance our understanding of the human condition.
I joined MIT Technology Review in March 2012 after a brief stint in the Washington, D.C., news bureau of the scientific journal Nature. Before I ventured to the East Coast, I spent several years in the San Francisco Bay Area as a doctoral student in molecular biology and one whirlwind year in science-writing boot camp in Santa Cruz.
In California, I wrote for the Stanford University press offices, the Multiple Sclerosis Discovery Forum, and the Salinas Californian newspaper. I grew up in a small town in eastern Texas, surrounded by bird song, rolling cattle fields, and lanky pine trees. When I’m not exploring health tech, you will probably find me cooking or giggling over an exceptional LOLcat.
Susan Young's Stories
An upcoming film, The Perfect 46, is about a fictional genomics company with a not-so-fictional idea.
Researchers show off flashing fish brains and the technology behind them.
Glowing bunnies are a successful early step in a project aimed at engineering mammals that produce medicines in their milk.
A detailed neuron-wiring diagram of the fruit fly's optic lobe helps explain how neurons work together to compute data.
An effort to build a public database of BRCA gene variants joins with Silicon Valley startup Syapse.
Scientists turn embryonic stem cells into photoreceptors that can integrate into a live retina.
With embryonic stem cells in clinical trials in the U.S. and the U.K., France looks to keep up.
DNA analysis continues its baby boom.
Patients with blindness caused by retinitis pigmentosa can now get a light-detecting microchip implanted in one of their retinas.